Trial Details

Not Recruiting
Basic Information
Clinical ID c2905
Identifier DRKS00011185
Trial Title Prevalence of vitamin D deficiency in patients with inflammatory bowel disease - VITAceD
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions K50.9 K51.9;Crohn disease, unspecified;Ulcerative colitis, unspecified;K50.9;K51.9
Interventions Group 1: After informed consent, all patients will receive information material regarding vitamin D in the context of IBD. They will fill questionnaires regarding the history of their disease and current disease activity. Blood tests for blood cell counts, electrolytes, creatinine, c-reactive protein, ferritin and vitamin B12 as well as a stool sample to determine fecal calprotectin concentrations will be collected. Additional serum will be frozen for the determination of vitamin D concentrations and additional inflammatory cytokines. Disease activity and vitamin D serum concentrations will be re-assessed after 6 (+/- 3) months.
Participant Information
Sponsor Universitsklinikum Freiburg
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date 2023-01-23
Completion Date 2019-06-30